Noticias tecnicas,cientificas,relacionadas con la sociedad de la información y la ciencia
traductor
lunes, 18 de noviembre de 2024
El fantasma de la obesidad del pasado: cómo el tejido adiposo recuerda la obesidad-Las células adiposas guardan "memoria" de la obesidad
Incluso después de una pérdida drástica de peso, las células grasas del cuerpo conservan la “memoria” de la obesidad, un hallazgo que podría ayudar a explicar por qué puede ser difícil mantenerse en forma después de un programa de pérdida de peso. Este "recuerdo" surge porquela obesidad conduce a cambios en el epigenoma, que son un conjunto de etiquetas químicas que se pueden agregar o eliminar del ADN y las proteínas de las células que ayudan a aumentar o disminuir la actividad genética. En el caso de las células grasas, este cambio incapacitarlas para realizar su función normal.
Este deterioro, así como los cambios en la actividad genética, pueden persistir mucho después de haber alcanzado el peso ideal a niveles saludables. Las personas que intentan adelgazar a menudo necesitarán cuidados a largo plazo para evitar recuperar peso
Reducir y mantener el peso corporal es fundamental para combatir la obesidad, pero el organismo parece conservar una memoria metabólica que impide el éxito a largo plazo. En este trabajo exploramos este fenómeno y demostramos que las células del tejido adiposo humano y de ratón conservan una memoria obesogénica funcional tras una pérdida de peso
Las células adiposas guardan "memoria" de la obesidad, un indicio de por qué es difícil no engordar.
Los cambios duraderos en el epigenoma de las células están relacionados con el deterioro de su función.
This memory arises because the experience of obesity leads to changes in the epigenome — a set of chemical tags that can be added to or removed from cells’ DNA and proteins
that help to dial gene activity up or down. For fat cells, the shift in
gene activity seems to render them incapable of their normal function.
This impairment, as well as the changes in gene activity, can linger
long after weight has dropped to healthy levels, a study published today
in Nature reports.
The results suggest that people trying
to slim down will often require long-term care to avoid weight regain,
says study co-author Laura Hinte, a biologist at ETH Zurich in
Switzerland. “It means that you need more help, potentially,” she says.
“It’s not your fault.”
Although we’ve long known that the body
tends to revert to obesity after weight loss, “how and why this happens
was almost like a black box”, says Hyun Cheol Roh, an epigenome
specialist at Indiana University School of Medicine in Indianapolis who
studies metabolism. The new results “show what’s happening at the
molecular level, and that’s really cool”.
A lingering memory
To
understand why weight can pile back on so quickly after it is lost,
Hinte and her colleagues analysed fat tissue from a group of people with
severe obesity, as well as from a control group of people who had never
had obesity. They found that some genes were more active in the obesity
group’s fat cells than in the control group’s fat cells, whereas other
genes were less active.
Even weight-loss surgery
did not budge that pattern. Two years after the participants with
obesity had had weight-reduction operations, they had lost large amounts
of weight — but their fat cells’ genetic activity still displayed the
obesity-linked pattern. The scientists found similar results in mice
that had lost large amounts of weight.
In the fat cells of both humans and mice, the genes dialled up during obesity are involved in spurring inflammation and fibrosis
— the formation of stiff, scar-like tissue. The genes that are turned
down help fat cells to function normally. Research on mice traced these
shifts in gene activity to changes in the epigenome, which has a powerful effect on how active a gene is, including whether it is turned on at all.
The
scientists tested the durability of these changes by putting obese mice
on a diet. A few months after the mice had become lean again, the
changes in their epigenomes persisted, as if the cells ‘remembered’
being in a body with obesity.
Rapid regain
It’s not clear
how long the body remembers obesity for, says study co-author Ferdinand
von Meyenn, an epigenome specialist at ETH Zurich. “There may be a time
window when this memory will be lost,” he says. “But we don’t know.”
To
better understand the effects of this memory, the researchers studied
fat cells from mice that had slimmed down after being obese. These cells
absorbed more sugar and fat than did fat cells from control mice that
had never been obese. The formerly obese mice also gained weight faster
on a high-fat diet than control mice did.
But
scientists not involved in the study, including Roh, note that the
paper doesn’t prove that the epigenetic alterations caused the physical
changes in the mice. The paper’s list of epigenetic alterations in fat
cells is valuable, says biologist Evan Rosen at Beth Israel Deaconess
Medical Center in Boston, Massachusetts, who studies fat tissue, but it
will be difficult to determine which of those changes drive the fat
cells’ lingering memory.
“It’s not yet a causal link,” agrees von Meyenn. “It’s correlation. … We’re working on this.”
Preventing
obesity to begin with is key, von Meyenn adds. People who lose weight
“can [stay] lean, but it will require a lot of effort and energy to do
that”, he says, adding that his team’s findings could help to remove
some of the stigma surrounding obesity.
doi: https://doi.org/10.1038/d41586-024-03614-9
References
Hinte, L. C. et al.Nature https://doi.org/10.1038/s41586-024-08165-7 (2024).
Reducing body weight to improve metabolic health and related comorbidities is a primary goal in treating obesity1,2.
However, maintaining weight loss is a considerable challenge,
especially as the body seems to retain an obesogenic memory that defends
against body weight changes3,4.
Overcoming this barrier for long-term treatment success is difficult
because the molecular mechanisms underpinning this phenomenon remain
largely unknown. Here, by using single-nucleus RNA sequencing, we show
that both human and mouse adipose tissues retain cellular
transcriptional changes after appreciable weight loss. Furthermore, we
find persistent obesity-induced alterations in the epigenome of mouse
adipocytes that negatively affect their function and response to
metabolic stimuli. Mice carrying this obesogenic memory show accelerated
rebound weight gain, and the epigenetic memory can explain future
transcriptional deregulation in adipocytes in response to further
high-fat diet feeding. In summary, our findings indicate the existence
of an obesogenic memory, largely on the basis of stable epigenetic
changes, in mouse adipocytes and probably other cell types. These
changes seem to prime cells for pathological responses in an obesogenic
environment, contributing to the problematic ‘yo-yo’ effect often seen
with dieting. Targeting these changes in the future could improve
long-term weight management and health outcomes.
Main
Obesity and its related comorbidities represent substantial health risks1.
A primary clinical objective in managing obesity is to achieve
appreciable weight loss (WL), typically through rigorous dietary and
lifestyle interventions, pharmaceutical treatments or bariatric surgery
(BaS)2.
Strategies relying on behavioural and dietary changes frequently only
result in short-term WL and are susceptible to the ‘yo-yo’ effect, in
which individuals regain weight over time3,5,6. This recurrent pattern may be partially attributable to an (obesogenic) metabolic memory that persists even after notable WL4,7,8,9,10 or metabolic improvements11,12,13.
Indeed, lasting phenotypic changes from previous metabolic states, that
is, metabolic memory, have been reported in mouse adipose tissue (AT)
or the stromal vascular fraction (SVF)14,15,16, whereas in liver these were reversible15,16,17. Persistent alterations after WL in the immune compartment18, and transcriptional and functional memory of obesity in endothelial cells of many organs19,20,21,22, have also been reported.
Epigenetic
mechanisms and modifications are essential for development,
differentiation and identity maintenance of adipocytes in vitro and in
vivo23,24,25,26,27, but are also expected to be crucial contributors to the cellular memory of obesity4,7.
For example, lasting chromatin accessibility changes have been
associated with pathological memory of obesity in mouse myeloid cells28 and, also, cold exposure studies have indicated the existence of (epigenetic) cellular memory26,29.
Hitherto, most human studies have focused on DNA methylation analysis
in bulk tissues or whole blood to assess putative cellular memory30,31,32,33.
These reports might be confounded by variations in cell type
composition, which are poorly characterized in the AT during WL, and
therefore serve foremost as indicators of cellular epigenetic memory.
In
summary, it remains unresolved whether individual cells retain a
metabolic memory and whether it is conferred through epigenetic
mechanisms. Here, we set out to address this by first performing
single-nucleus RNA sequencing (snRNA-seq) of AT from individuals living
with obesity before and after significant WL, as well as lean, obese and
formerly obese mice, confirming the presence of retained
transcriptional changes, and, second, by characterizing the epigenome of
mouse adipocytes, which revealed the long-term persistence of an
epigenetic obesogenic memory.
Transcriptional changes in human AT
To
explore whether signatures of previous obesogenic states persist in
humans after appreciable WL, we obtained subcutaneous AT (scAT) and
omental AT (omAT) biopsies from individuals with healthy weight who have
never had obesity (called healthy weight here) and people living with
obesity (but without diabetes) before (T0) and 2 yr after (T1) BaS from
multiple independent studies (Fig. 1a).
The Ghost of Obesity Past : How Adipose Tissue Remembers Obesity
Reducing and maintaining body weight are key in tackling obesity, but
the body seems to retain a metabolic memory impeding long-term success.
Here, we explore this phenomenon and show that cells in human and mouse
adipose tissue retain a functional obesogenic memory after substantial
weight loss.
How It All Began
This
project stemmed from our curiosity about whether cells retain an
epigenetic memory of prior metabolic states. Epigenetic memory is
well-known for explaining how daughter cells maintain their
transcriptional identity through cell division, playing a vital role in
development, regeneration, and growth. But what about non-dividing
cells? They too must adapt to external stimuli and therefore undergo
epigenetic adaptations. If so, are these changes embedded in the
epigenome during chronic conditions like obesity? And, most importantly,
are they fully reversible?
Obesity
is a chronic condition with significant metabolic consequences,
strongly linked to various metabolic and cardiovascular diseases. A
well-documented observation is that the body tends to defend increased
body weight, making weight loss and maintenance notoriously challenging.
This could be due to a type of "metabolic memory," where the body
remembers and strives to return to its former state of obesity. This
notion has been explored in the context of improving glycemic control in
diabetes, where metabolic improvements can have lasting effects, even
if control is lost again.
Could
epigenetic changes at the cellular level drive this metabolic memory in
obesity? One metabolic organ heavily impacted by both obesity and
weight loss is adipose tissue. Adipocytes, with a remarkable lifespan of
around 10 years, do not divide, making them an ideal model for studying
epigenetic memory. Additionally, adipose tissue is easily accessible
for human biopsies, allowing for longitudinal studies—something not
feasible for most other organs.
Our study focused on three main areas:
The cellular remodeling of adipose tissue after weight loss.
Investigating transcriptional memory across all adipose tissue cell types using single-nucleus RNA sequencing (snRNAseq).
Using mouse models to analyze the epigenetic changes in adipocytes and assess their retention post-obesity.
What we found
We collected human subcutaneous and
visceral adipose tissue biopsies from 20 individuals living with obesity
but without metabolic disease. These samples were obtained both pre-
and post-bariatric surgery, with substantial weight loss over two years.
Collaborators from Germany and Sweden provided the biopsies. Using
snRNAseq, we compared gene expression across various cell types in
adipose tissue during obesity and after weight loss to cells from normal
weight donors.
Unsurprisingly, we found differences in gene
expression between cells from obese and lean individuals. However, the
most striking discovery was that many of these differences persisted
even after significant weight loss. This phenomenon was especially
prominent in adipocytes, endothelial cells, and precursor cells,
suggesting that these cells retain a transcriptional memory of obesity
that remains long after weight reduction.
However, given the inherent limitations of human
studies, such as genetics, nutritional status, the environment etc., we
extended our analysis to mice. We induced obesity in mice through a
high-fat diet (HFD) and then reversed it by switching them back to a
standard chow diet. Unlike most dieting humans, mice achieved rapid
weight loss, reaching body weights comparable to age-matched controls
within 4-8 weeks. They exhibited normal metabolic function, including
liver fat clearance, normalised insulin and leptin levels, and showing a
near-complete restoration of energy expenditure.
Despite these apparent recoveries, the snRNAseq
analysis of their adipose tissue revealed that adipocytes, endothelial
cells, and precursors retained a transcriptional memory of obesity,
consistent with our human data. This finding confirmed that metabolic
memory is not exclusive to humans.
To further explore the epigenetic landscape of adipocytes, we leveraged two advanced techniques: Adipocyte specific reporter mice and chromatin profiling methods (CUT&Tag),
allowing us to examine four specific epigenetic marks (H3K4me3,
H3K27me3, H3K4me1, H3K27ac) known to regulate gene expression and
chromatin structure. We specifically analyzed adipocytes that had
existed prior to HFD exposure to ensure consistency across experimental
and control groups. Our results showed obesity-induced epigenetic
changes at thousands of loci, affecting all four marks and accessbility.
In line with our transcriptomic findings, many of these changes
persisted after weight loss. For instance, promoters that should be
active remained silenced, and the enhancer landscape was remodeled,
suggesting that adipocytes truly retain an epigenetic memory of obesity.
Cuando desafiamos a estos adipocitos retenedores de memoria con palmitato y glucosa ex vivo, mostraron una respuesta más rápida en comparación con los controles. Del mismo modo, los ratones recuperaron peso más rápidamente cuando se les reintrodujo una dieta rica en grasas, y su tejido adiposo se expandió a mayor velocidad. La memoria epigenética pudo incluso predecir diferencias en la expresión génica tras la reintroducción. Estas observaciones indican que la memoria epigenética predispone a los individuos anteriormente obesos a recuperar peso más fácilmente, lo que pone de relieve las consecuencias a largo plazo de la obesidad sobre la función del tejido adiposo.
Why It Matters
This is one of the first studies to demonstrate
that specific cell types can retain an epigenetic memory of a prior
metabolic state. This finding has profound implications for our
understanding of obesity, weight loss, and weight maintenance. On a
societal level, this could offer some solace to individuals struggling
with obesity, as it suggests that the difficulty in maintaining weight
loss may not be due solely to a lack of willpower or motivation, but
rather to a deeper cellular memory that actively resists change.
Moreover, if such epigenetic memories are found in
other cell types, such as neurons, or in contexts like addiction, it
could open new avenues for therapeutic interventions. Understanding and
potentially reversing these epigenetic changes could have far-reaching
implications for treating chronic conditions associated with metabolic
memory.
What’s Next?
The question remains: why isn’t this epigenetic
memory erased over time? Could it be because adipocytes do not divide?
Or perhaps other cell types are similarly affected? Could it be that we
merely need to stay lean long enough for the memory to vanish? The next
steps will involve developing tools to precisely modify the epigenome at
hundreds of loci to test whether altering these marks can reverse the
obesogenic memory and its associated phenotypes. Additionally, it will
be crucial to investigate whether long-lived cells, such as neurons in
the hypothalamus, also retain an epigenetic memory of obesity.
No hay comentarios:
Publicar un comentario